Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 10/20 | 0.39 |
| ▸ | NOS2 | P35228 | 10/20 | 0.39 |
| ▸ | NOS3 | P29474 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.31 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21381501 | 0.84 | CYP1A2 (0.43) | CYP1A2NOS1NOS2NOS3LMNA | |
| SCHEMBL16190155 | 0.77 | — | — | |
| SCHEMBL27687139 | 0.76 | NOS1 (0.39) | CYP1A2NOS1NOS2NOS3LMNA | |
| SCHEMBL12166923 | 0.76 | FUCA1 (0.44) | CYP1A2LMNAMAPK1HTT | |
| SCHEMBL5870459 | 0.74 | CYP1A2 (0.46) | CYP1A2NOS1NOS2LMNAMAPK1 | |
| SCHEMBL11904251 | 0.72 | CYP1A2 (0.48) | CYP1A2NOS1NOS2NOS3LMNA | |
| SCHEMBL21382099 | 0.72 | SIGMAR1 (0.30) | — | |
| Butylamine SCHEMBL8163651 | 0.72 | DNM1 (0.46) | NOS1NOS2NOS3 | |
| SCHEMBL20604050 | 0.72 | — | — | |
| SCHEMBL18799425 | 0.71 | CYP1A2 (0.48) | CYP1A2NOS1NOS2LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023150667-A2 | RIBOSE LINKERS AND CONJUGATES THEREOF | ELYSIUM HEALTH INC. (US) | 2023-08-10 | — | — | WO | disclosed |